Regenerative Stem Cell Therapy for Stroke in Europe "RESSTORE"

Withdrawn

Phase 2/3 Results N/A

Summary of Purpose

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of... Trial Stopped: Not authorized by Regulatory agencies - new protocol phase 1a in progress

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 January 2018.

1 Mar 2016 6 Jul 2016 1 Sep 2017 1 Sep 2017 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts